59% of prostate cancer patients receive treatment without understanding their treatment options

Low Dose Rate Brachytherapy Boost: Latest Scientific Evidence on Outcome Survival Rates Indicates LD

Sowing the seeds of knowledge in brachytherapy

BXTAccelyon to host Benelux LDR Brachytherapy event endorsed by ABRO/BVRO

Prostate cancer: Know your treatment options

BXTAccelyon becomes sole distribution partner for new transperineal prostate biopsy device

Prostate Cancer: men should be given wider access to treatment options available

PrecisionPoint™ Transperineal Access System – New Zealand workshops

The crucial role of a Clinical Nurse Specialist (CNS)

Upcoming events, workshops and conferences